Key Points
- NewGenIvf Group major shareholder Financial Lp Hrt sold 85,317 shares on May 27 at an average price of $0.80, worth about $68,253.60. After the sale, the insider’s stake fell to 54,561 shares, a 60.99% decrease in ownership.
- The same shareholder also bought shares on two prior days, including 27,993 shares on May 26 and 137,541 shares on May 22. Those purchases totaled more than $161,000, showing recent active trading in the stock.
- NIVF shares opened at $1.03, while the company reported a quarterly EPS of -$287.24 on revenue of $1.42 million. Analysts currently maintain a Sell consensus rating on the stock.
NewGenIvf Group Limited (NASDAQ:NIVF - Get Free Report) major shareholder Financial Lp Hrt sold 85,317 shares of the business's stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $0.80, for a total transaction of $68,253.60. Following the transaction, the insider owned 54,561 shares of the company's stock, valued at approximately $43,648.80. This represents a 60.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.
Financial Lp Hrt also recently made the following trade(s):
- On Tuesday, May 26th, Financial Lp Hrt acquired 27,993 shares of NewGenIvf Group stock. The shares were purchased at an average price of $0.92 per share, with a total value of $25,753.56.
- On Friday, May 22nd, Financial Lp Hrt acquired 137,541 shares of NewGenIvf Group stock. The shares were purchased at an average price of $0.99 per share, with a total value of $136,165.59.
NewGenIvf Group Price Performance
Shares of NIVF opened at $1.03 on Friday. NewGenIvf Group Limited has a one year low of $0.72 and a one year high of $1,839.00. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.98 and a current ratio of 3.12. The firm has a 50 day simple moving average of $1.66 and a two-hundred day simple moving average of $6.74.
NewGenIvf Group (NASDAQ:NIVF - Get Free Report) last announced its quarterly earnings data on Tuesday, March 31st. The company reported ($287.24) EPS for the quarter. The business had revenue of $1.42 million for the quarter. On average, equities research analysts anticipate that NewGenIvf Group Limited will post 4.74 EPS for the current year.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reaffirmed a "sell (d)" rating on shares of NewGenIvf Group in a research note on Monday, April 27th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of "Sell".
Read Our Latest Research Report on NIVF
NewGenIvf Group Company Profile
(
Get Free Report)
NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People's Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.
NewGenIVF's service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
